# Longitude Capital: portfolio, investments and team > Longitude Capital is a vc firm based in United States. 97 investments on record, 7 in the last 12 months, latest Jun 2026. Source: https://millionrounds.com/fund/longitude-capital (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Longitude Capital Last cheque observed Jun 2026; 97 cheques on record. Email Deploying now New fund $100M, Nov 2025 VC firm Seed Series A Series B Med Device Medical Devices Health Follow Longitude Capital and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Flongitude-capital) Deploying now **70%** of best year **7** **cheques in 12 months**, 97 on record Since the last cheque **136** days **00** hrs **00** min **00** sec Median round **$60M** Cheque size, as they say **$100K – $5.0M** Rounds led **0 of 97** Sole investor **10 rounds** Exits **4 from the portfolio** Mostly in **United States, 89%** Pitch Longitude Capital ## Longitude Capital highlights - 01 7 cheques in the last 12 months - 02 Mostly Series A and Venture: 49% of its rounds - 03 Sole investor in 10 rounds, median $17M - 04 4 exits from the portfolio ## What they do > Longitude Capital specializes in making venture growth investments in biotechnology, medical technology, and health solutions companies From their own website - **Type:** VC firm (from a list, unverified) - **Cheque size:** $100K – $5.0M as they say - **Stages:** Seed Series A Series B Growth Pre-IPO - **Sectors:** Med Device Medical Devices Health - **Based in:** Menlo Park, United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **97 appearances** - **2026** 5 rounds - **Jun** **[cAMPfield Therapeutics, Inc.](https://millionrounds.com/company/campfield-therapeutics-inc)** Series A · US · Frazier Life Sciences **$180M** With 7 others - **Apr** **[VeraDermics](https://millionrounds.com/company/veradermics)** US **$384M** With 3 others - **Mar** **[Polares Medical](https://millionrounds.com/company/polares-medical)** Series C · US **$50M** With 2 others - **Jan** **[AirNexis Therapeutics](https://millionrounds.com/company/airnexis-therapeutics)** Series A · US **$200M** With 2 others - **Jan** **[Ventaris Surgical](https://millionrounds.com/company/ventaris-surgical)** Series A · US · Firms' own news pages **$30M** With 4 others - **2025** 8 rounds - **Dec** **[Kestra Medical Technologies, Inc.](https://millionrounds.com/company/kestra-medical-technologies-inc)** US **$138M** With 3 others - **Dec** **[Vera Therapeutics](https://millionrounds.com/company/vera-therapeutics)** US **$261M** With 3 others - **Sept** **[Nalu Medical](https://millionrounds.com/company/nalu-medical)** Venture · US **$50M** With 3 others - **May** **[Cohere Health](https://millionrounds.com/company/cohere-health)** Series C · US **$90M** With 4 others - **Mar** **[MicroTransponder](https://millionrounds.com/company/microtransponder)** Series F · US **$65M** Sole investor - **Jan** **[Rivus Pharmaceuticals](https://millionrounds.com/company/rivus-pharmaceuticals)** Venture · US **$57M** With 2 others - **Jan** **[Helicore Biopharma](https://millionrounds.com/company/helicore-biopharma)** Series A · US **$65M** With 3 others - **Jan** **[89bio](https://millionrounds.com/company/89bio)** US **$288M** With 2 others - **2024** 7 rounds - **Nov** **[Alentis Therapeutics](https://millionrounds.com/company/alentis-therapeutics)** Series D · CH · Avego Management **$181M** With 11 others - **Nov** **[Cortica](https://millionrounds.com/company/cortica)** Venture · IL **$80M** With 5 others - **Sept** **[CuraSen Therapeutics](https://millionrounds.com/company/curasen-therapeutics)** Venture · US **$5.8M** Sole investor - **Sept** **[OrsoBio](https://millionrounds.com/company/orsobio)** Series B · US **$67M** With 2 others - **Jun** **[Endogenex](https://millionrounds.com/company/endogenex)** Series C · US · Hatteras Venture Partners **$88M** With 6 others - **May** **[Zenas BioPharma](https://millionrounds.com/company/zenas-biopharma)** Series C · US · Tellus BioVentures **$200M** With 14 others - **Jan** **[Nalu Medical](https://millionrounds.com/company/nalu-medical)** Series E · US **$85M** With 1 other - **2023** 4 rounds - **Dec** **[Lassen Therapeutics](https://millionrounds.com/company/lassen-therapeutics)** Series B · US **$85M** With 2 others - **Aug** **[Poseida Therapeutics](https://millionrounds.com/company/poseida-therapeutics)** US **$25M** With 4 others - **May** **[Quanta Therapeutics](https://millionrounds.com/company/quanta-therapeutics)** Series D · US **$51M** With 1 other - **Jan** **[NOCD](https://millionrounds.com/company/nocd)** Series B · US · Cigna Ventures **$34M** With 6 others - **2022** 10 rounds - **Nov** **[Eargo](https://millionrounds.com/company/eargo)** US **$29M** With 4 others - **Nov** **[Opna Bio](https://millionrounds.com/company/opna-bio)** Series A · CH **$38M** With 2 others - **Nov** **[Aptinyx](https://millionrounds.com/company/aptinyx)** Grant · US **$5.6M** With 3 others - **Oct** **[Tricida](https://millionrounds.com/company/tricida)** Debt · US **$125M** With 5 others - **Sept** **[Ceribell](https://millionrounds.com/company/ceribell)** Series C · US **$50M** With 2 others - **Aug** **[Axonics Modulation Technologies](https://millionrounds.com/company/axonics-modulation-technologies)** US **$112M** With 4 others - **Apr** **[IntelyCare](https://millionrounds.com/company/intelycare)** Series C · US **$115M** With 2 others - **Apr** **[LimFlow SA](https://millionrounds.com/company/limflow-sa)** Series D · FR **$39M** With 2 others - **Mar** **[Dascena](https://millionrounds.com/company/dascena)** Venture · US **Undisclosed** With 2 others - **Jan** **[AvengeBio](https://millionrounds.com/company/avengebio)** Series A · US **$45M** With 1 other - **2021** 3 rounds - **Aug** **[Sydnexis](https://millionrounds.com/company/sydnexis)** Series B · US **$45M** With 1 other - **Apr** **[Theseus Pharmaceuticals](https://millionrounds.com/company/theseus-pharmaceuticals)** Series B **$100M** With 4 others - **Jan** **[Zavante Therapeutics](https://millionrounds.com/company/zavante-therapeutics)** Venture **Undisclosed** Sole investor - **2020** 2 rounds - **Oct** **[Alphaeon](https://millionrounds.com/company/alphaeon)** Venture **$20M** Sole investor - **Feb** **[Aimmune Therapeutics](https://millionrounds.com/company/aimmune-therapeutics)** **$200M** With 4 others - **2019** 7 rounds - **Dec** **[Epirium Bio](https://millionrounds.com/company/epirium-bio)** Series A · US · Startuparound **$85M** With 5 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **5 named** CE **Carolyn Elizabeth Helms** Managing Director / Chief Financial Officer of Longitude Capital Management Co., LLC i Form ADV CB **Cristiana Blauth Oliveira** Chief Compliance Officer of Longitude Capital Management Co., LLC i Form ADV JP **Juliet Priscilla Tammenomsbakker** Managing Member of Longitude Capital Management Co., LLC i Form ADV JT **Juliet Tammenoms Bakker** Managing Member of the General Partner i Filing they signed PG **Patrick Gerald Enright** Managing Member of Longitude Capital Management Co., LLC i Form ADV We also hold **25** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **$2.4B** assets it manages Oct 2026 **Registered** investment adviser full reporting to the SEC - **Legal name:** Longitude Capital Management Co., LLC - **SEC number:** CRD 161916 Funds on its Form ADV **5** private funds, **$1.7B** in gross assets · filed Mar 2024 - Longitude Venture Partners IV, L.P. *Venture* 80 investors $639M - Longitude Venture Partners III, L.P. *Venture* 70 investors $459M - Longitude Venture Partners V, L.P. *Venture* 50 investors $336M - Longitude Prime Fund, L.P. *Venture* 35 investors $142M - Longitude Venture Partners II, L.P. *Venture* 50 investors $95M ## What they claim to have backed From their own portfolio page (on their website) **39** of 60 we have independently watched raise [89bio](https://millionrounds.com/company/89bio)[Alentis](https://millionrounds.com/company/alentis-therapeutics)[Avengebio](https://millionrounds.com/company/avengebio)[Axonics](https://millionrounds.com/company/axonics)[Bioagelabs](https://millionrounds.com/company/bioage-labs)[Ceribell](https://millionrounds.com/company/ceribell)[Cgoncology](https://millionrounds.com/company/cg-oncology)[Checkmatepharma](https://millionrounds.com/company/checkmate-pharmaceuticals)[Coherehealth](https://millionrounds.com/company/cohere-health)[Curasen](https://millionrounds.com/company/curasen)[Dascena](https://millionrounds.com/company/dascena)[Eargo](https://millionrounds.com/company/eargo)[Endeavorbiomedicines](https://millionrounds.com/company/endeavor-biomedicines)[Epirium](https://millionrounds.com/company/epirium-bio)[Fire1foundry](https://millionrounds.com/company/fire1)[Helomics](https://millionrounds.com/company/helomics)[Infinanthealth](https://millionrounds.com/company/infinant-health)[Inflazome](https://millionrounds.com/company/inflazome)[Inozyme](https://millionrounds.com/company/inozyme)[Intelycare](https://millionrounds.com/company/intelycare)[Lassentherapeutics](https://millionrounds.com/company/lassen-therapeutics)[Limflow](https://millionrounds.com/company/limflow)[Microtransponder](https://millionrounds.com/company/microtransponder)[Murj](https://millionrounds.com/company/murj)[Opnabio](https://millionrounds.com/company/opna-bio)[Orbustherapeutics](https://millionrounds.com/company/orbus-therapeutics)[Orsobio](https://millionrounds.com/company/orsobio)[Polaresmedical](https://millionrounds.com/company/polares-medical)[Poseida](https://millionrounds.com/company/poseida-therapeutics)[Practicefusion](https://millionrounds.com/company/practice-fusion)[Somatus](https://millionrounds.com/company/somatus)[Sydnexis](https://millionrounds.com/company/sydnexis)[Tourmalinebio](https://millionrounds.com/company/tourmaline-bio)[Tricida](https://millionrounds.com/company/tricida)[Vaxcyte](https://millionrounds.com/company/vaxcyte)[Ventarissurgical](https://millionrounds.com/company/ventaris-surgical)[Venusconcept](https://millionrounds.com/company/venus-concept)[Veradermics](https://millionrounds.com/company/veradermics)[Welbehealth](https://millionrounds.com/company/welbehealth) A9oncology Aeonbiopharma Aimmune Airnexis Akebia Amarincorp Assemblybio Baronova Boltmed Collegiumpharma Corcept Corticacare Crownwheelpartners Esperion Generate Helicore Jazzpharma Kestramedical Mirumpharma Nabriva Nalumed and 9 more Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded. ## Exits from the portfolio Companies it backed that were later bought or listed **4 in all** **[AqueSys](https://millionrounds.com/company/aquesys)** Bought by [Allergan](https://millionrounds.com/fund/allergan) **$300M** Sept 2015 **[Civitas Therapeutics](https://millionrounds.com/company/civitas-therapeutics)** Bought by Acorda Therapeutics **$525M** Sept 2014 **[PreCision Dermatology](https://millionrounds.com/company/precision-dermatology)** Bought by Valeant Pharmaceuticals International **$500M** Feb 2014 **[Solta Medical](https://millionrounds.com/company/solta-medical)** Bought by Valeant Pharmaceuticals International **$250M** Dec 2013 An exit counts when it came after the firm's first round in the company. From historical deal records. New fund on file **$100M** raised in Nov 2025 From its SEC filing, not a journalist: a firm that has just raised has money to deploy. ## The cheque Seed Series A Series B Median round joined **$60M** the round, not its cheque Alone, median **$17M** Led 0 of 97 rounds **0%** - **Said size:** $100K – $5.0M - **Sole investor:** 10 rounds - **Last cheque:** Jun 2026 - **Exits:** 4 from the portfolio Rounds by stage said on their site - Series A said *19* - Venture *17* - Series B said *17* - Series C *12* - Series D *8* - Seed said *-* - Growth said *-* Cheques by month Led Joined Dec 2023 Nov 2026 Often in the room with - [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) 14 - [OrbiMed](https://millionrounds.com/fund/orbimed) 10 - [Kleiner Perkins Caufield & Byers](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers) 7 - [Adage Capital Management](https://millionrounds.com/fund/adage-capital-management) 6 - [Asset Management Ventures](https://millionrounds.com/fund/asset-management-ventures) 5 - [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) 5 **Pitching Longitude Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Longitude Capital. A count of rooms they were both in, not a relationship either has claimed. [**RA Capital Management** Private equity **14** rounds together](https://millionrounds.com/fund/ra-capital-management)[**OrbiMed** Private equity **10** rounds together](https://millionrounds.com/fund/orbimed)[**Kleiner Perkins Caufield & Byers** VC firm **7** rounds together](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers)[**Adage Capital Management** Asset manager **6** rounds together](https://millionrounds.com/fund/adage-capital-management)[**Asset Management Ventures** VC firm **5** rounds together](https://millionrounds.com/fund/asset-management-ventures)[**New Enterprise Associates** VC firm **5** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**Quaker Partners** VC firm **5** rounds together](https://millionrounds.com/fund/quaker-partners)[**TPG** Private equity **5** rounds together](https://millionrounds.com/fund/tpg)[**Wellington Management** VC firm **5** rounds together](https://millionrounds.com/fund/wellington-management)[**Adams Street Partners** VC firm **4** rounds together](https://millionrounds.com/fund/adams-street-partners)[**Bain Capital Life Sciences** Private equity **4** rounds together](https://millionrounds.com/fund/bain-capital-life-sciences)[**Fidelity** VC firm **4** rounds together](https://millionrounds.com/fund/fidelity) ## Recently backed The latest companies Longitude Capital put money into. [**VeraDermics** $384M · Apr 2026](https://millionrounds.com/company/veradermics)[**AirNexis Therapeutics** $200M · Jan 2026](https://millionrounds.com/company/airnexis-therapeutics)[**Ventaris Surgical** $30M · Jan 2026](https://millionrounds.com/company/ventaris-surgical)[**Kestra Medical Technologies, Inc.** $138M · Dec 2025](https://millionrounds.com/company/kestra-medical-technologies-inc)[**Vera Therapeutics** $261M · Dec 2025](https://millionrounds.com/company/vera-therapeutics)[**Nalu Medical** $50M · Sept 2025](https://millionrounds.com/company/nalu-medical) ## Quick answers about Longitude Capital ### What does Longitude Capital invest in? Longitude Capital invests most often at Series A and Venture (49% of the rounds on record), in sectors such as Med Device, Medical Devices and Health. ### How active is Longitude Capital? 97 investments on record, 7 of them in the last 12 months. The most recent was in Jun 2026. ### What has Longitude Capital invested in recently? Its most recent investments on record: cAMPfield Therapeutics, Inc. (Series A, Jun 2026), VeraDermics (Undisclosed round, Apr 2026) and Polares Medical (Series C, Mar 2026). ### How big are Longitude Capital's cheques? The median round it joins is $60M. It says it writes cheques of $100K to $5.0M. ### Does Longitude Capital lead rounds? Rarely, if at all: none of its 97 investments on record names it as the lead. ### Where does Longitude Capital invest? Most of the companies it backs are in the United States (89%) and Switzerland (6%). ### Is Longitude Capital investing now? Yes: it is actively investing, with 7 investments in the last 12 months. ### Who does Longitude Capital invest alongside? Most often RA Capital Management (14 rounds together), OrbiMed (10 rounds together) and Kleiner Perkins Caufield & Byers (7 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=longitude-capital) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=longitude-capital)